Target intelligence / Profile preview

Phosphatidylinositol-specific phospholipase C X domain containing 1 (PLCXD1)

Target
PLCXD1
Molecular classification
Enzyme, Phosphoinositide-specific phospholipase C family
01

Overview

Phosphatidylinositol-specific phospholipase C X domain containing 1 (PLCXD1) is a human enzyme encoded by the PLCXD1 gene, which is located in the pseudoautosomal region 1 (PAR1) on both the X and Y chromosomes[1][5][9][13]. It contains a PI-PLC X domain, suggesting a function related to phospholipid signaling pathways and lipid metabolism, similar to other phosphoinositide-specific phospholipase C family members[1][6][8][10]. The specific enzymatic activity, regulatory mechanisms, and physiological substrates of PLCXD1 remain poorly characterized, and its biological functions have not been fully elucidated[7]. While several other phospholipase C isozymes play central roles in cellular signal transduction by generating second messengers from membrane phospholipids, the regulatory mechanisms and in vivo functions of PLCXDs, including PLCXD1, are currently unclear[7]. PLCXD1 is not recognized as a therapeutic target, and no drugs are known to selectively act on this protein[10]. Associations with diseases such as Leri-Weill Dyschondrosteosis and Osteochondrodysplasia are noted in gene databases but require further research for direct causal roles[10].

Other names
LL0XNC01-136G2.1PI-PLC X domain-containing protein 1PLCXD1
02

Biological functions

Lipid metabolic processPhospholipid signalingPhosphoric diester hydrolase activity
03

Disease associations

None established; rare disease links (Leri-Weill Dyschondrosteosis, Osteochondrodysplasia) are noted in gene association databases but direct mechanistic roles are unproven

Beyond the preview

Go deeper on Phosphatidylinositol-specific phospholipase C X domain containing 1 (PLCXD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol-specific phospholipase C X domain containing 1 (PLCXD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call